| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,940 | 1,010 | 23:00 | |
| 0,955 | 0,985 | 16:45 |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 22.05. | ACOTEC-B (06669): NOTIFICATION LETTER AND REPLY FORM TO NON-REGISTERED SHAREHOLDERS | - | HKEx | ||
| 22.05. | ACOTEC-B (06669): NOTIFICATION LETTER AND REPLY FORM TO REGISTERED SHAREHOLDERS | - | HKEx | ||
| 22.05. | ACOTEC-B (06669): FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD ON TUESDAY, JUNE 16, 2026 | - | HKEx | ||
| 22.05. | ACOTEC-B (06669): NOTICE OF ANNUAL GENERAL MEETING | 1 | HKEx | ||
| 22.05. | ACOTEC-B (06669): PROPOSALS FOR GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES; RE-ELECTION OF RETIRING DIRECTORS; RE-APPOINTMENT OF AUDITOR; ... | 1 | HKEx | ||
| 24.04. | ACOTEC-B (06669): NOTIFICATION LETTER AND REPLY FORM TO NON-REGISTERED SHAREHOLDERS | 1 | HKEx | ||
| 24.04. | ACOTEC-B (06669): NOTIFICATION LETTER AND REPLY FORM TO REGISTERED SHAREHOLDERS | 1 | HKEx | ||
| ACOTEC SCIENTIFIC Aktie jetzt für 0€ handeln | |||||
| 24.04. | ACOTEC-B (06669): 2025 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT | - | HKEx | ||
| 24.04. | ACOTEC-B (06669): 2025 ANNUAL REPORT | - | HKEx | ||
| 26.03. | ACOTEC-B (06669): PROPOSED AMENDMENTS TO THE MEMORANDUM AND ARTICLES OF ASSOCIATION AND ADOPTION OF THE NEW MEMORANDUM AND ARTICLES OF ASSOCIATION | 1 | HKEx | ||
| 26.03. | Acotec Scientific Holdings Limited Full Year Profit Climbs | 1 | RTTNews | ||
| 26.03. | ACOTEC-B (06669): ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2025 | - | HKEx | ||
| 16.03. | ACOTEC-B (06669): NOTICE OF BOARD MEETING | - | HKEx | ||
| 31.12.25 | ACOTEC-B (06669): POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON WEDNESDAY, DECEMBER 31, 2025 | 2 | HKEx | ||
| 16.12.25 | ACOTEC-B (06669): NOTIFICATION LETTER AND REPLY FORM TO NON-REGISTERED SHAREHOLDERS | 1 | HKEx | ||
| 16.12.25 | ACOTEC-B (06669): NOTIFICATION LETTER AND REPLY FORM TO REGISTERED SHAREHOLDERS | 2 | HKEx | ||
| 16.12.25 | ACOTEC-B (06669): FORM OF PROXY FOR THE EXTRAORDINARY GENERAL MEETING TO BE HELD ON WEDNESDAY, DECEMBER 31, 2025 | 1 | HKEx | ||
| 16.12.25 | ACOTEC-B (06669): NOTICE OF EXTRAORDINARY GENERAL MEETING | 1 | HKEx | ||
| 16.12.25 | ACOTEC-B (06669): CONTINUING CONNECTED TRANSACTIONS AND NOTICE OF EXTRAORDINARY GENERAL MEETING | 1 | HKEx | ||
| 12.12.25 | ACOTEC-B (06669): CONTINUING CONNECTED TRANSACTIONS | - | HKEx |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| RESMED | 157,95 | -1,50 % | Resmed, Inc.: Resmed Completes Acquisition of Noctrix Health, Expanding Clinical Sleep Health Portfolio | Acquisition adds Nidra Tonic Motor Activation (TOMAC) Therapy, an FDA De Novo classified, nonpharmacologic treatment designed to address moderate-to-severe Restless Legs Syndrome (RLS).SAN DIEGO, June... ► Artikel lesen | |
| CARDINAL HEALTH | 166,95 | -0,51 % | Neun Dividendenaufstockungen im Fokus: Was die jüngsten Erhöhungen von Cardinal Health, Constellation Energy & Co. für Einkommensinvestoren bedeuten | Mehrere US-Unternehmen haben Anfang Mai ihre Dividenden angehoben - darunter mit Cardinal Health und Constellation Energy zwei prominente Vertreter aus Gesundheitswesen und Versorgersektor. Die von... ► Artikel lesen | |
| ZIMMER BIOMET | 70,98 | -0,45 % | ZIMMER BIOMET HOLDINGS, INC. - 8-K, Current Report | ||
| UNIDOC HEALTH | 0,062 | +3,32 % | UniDoc Health Corp.: UniDoc Reflects on Successes One Year After AMD Telemedicine Software Purchase | AMD Telemedicine software and related systems now fully integrated; UniDoc Connect used at more than 800 sites across 48 countries VANCOUVER, BC / ACCESS Newswire / May 21, 2026 / UniDoc Health Corp.... ► Artikel lesen | |
| CO-DIAGNOSTICS | 6,240 | -26,85 % | Is Co-Diagnostics National Security's Next Diagnostic Pick? | ||
| CLARIANE | 4,002 | -2,58 % | Clariane: Minutes of the General Meeting of 12 May 2026 | Minutes of the General Meeting of 12 May 2026 Paris, 12 May 2026 - The Annual General Meeting of shareholders of Clariane (CLARI - ISIN: FR0010386334) was held on 12 May 2026 (the « General Meeting... ► Artikel lesen | |
| PANGENOMIC HEALTH | 0,225 | -2,60 % | XFRA LL3: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| VYOME | 2,320 | -0,85 % | Vyome Holdings, Inc. reports Q1 results | ||
| INSPIREMD | 0,775 | -9,88 % | InspireMD Inc.: InspireMD Reports First Quarter 2026 Financial Results | - Reports total Q1 2026 revenue of $3.4 million, representing year-over-year growth of 122% - - Received IDE approval from FDA to initiate the CGUARDIANS III clinical trial of its SwitchGuard... ► Artikel lesen | |
| IZOTROPIC | 0,160 | -3,03 % | Izotropic Corporation: Izotropic Africa Launches Operations in Casablanca | Vancouver, British Columbia and Casablanca, Morocco--(Newsfile Corp. - April 29, 2026) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic", or the "Company"), a medical device... ► Artikel lesen | |
| ORGANOGENESIS | 1,910 | -6,37 % | Truist initiates Organogenesis stock at Hold on reimbursement shifts | ||
| ASTRANA HEALTH | 31,600 | -2,47 % | Astrana Health, Inc. Reports First Quarter 2026 Results | Company to Host Conference Call on Thursday, May 7, 2026, at 2:30 p.m. PT/5:30 p.m. ET
Reports total revenue of $965.1 million, up 56% year over year
Reports... ► Artikel lesen | |
| CATHETER PRECISION | 0,980 | +11,74 % | Catheter Precision, Inc.: Flyte Increases Capacity and Launches Hiring Initiative as Spirit Airlines Shutdown Disrupts U.S. Air Travel | FORT MILL, SC, May 04, 2026 (GLOBE NEWSWIRE) -- - Flyte, the regional air mobility subsidiary of Catheter Precision, Inc. (NYSE American: VTAK) ("VTAK" or the "Company"), today announced increased... ► Artikel lesen | |
| ORIOLA | 0,920 | +0,44 % | Oriola Oyj: Acquisition of own shares during week 22, 2026 | ||
| CROSSJECT | 2,085 | -5,66 % | CROSSJECT announces the successful completion of an equity financing and warrant issuance for a total immediate gross amount of €15 million | Provides immediate new financing to support the Company's next strategic milestones Strengthens shareholders' equity and improves the Company's financial structure Supports the continuation of ZEPIZURE®... ► Artikel lesen |